Evidence map›Paper›PMID 39252889›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Digital language markers distinguish frontal from right anterior temporal lobe atrophy in frontotemporal dementia.

Jet M J Vonk, Brittany T Morin, Janhavi Pillai, David Rosado Rolon, Rian Bogley, David Paul Baquirin, Zoe Ezzes, Boon Lead Tee, Jessica DeLeon, Lisa Wauters and 9 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Jet M J VonkMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-1808-8843
Brittany T MorinMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Janhavi PillaiMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
David Rosado RolonMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Rian BogleyMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
David Paul BaquirinMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Zoe EzzesMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Boon Lead TeeMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Jessica DeLeonMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Lisa WautersDepartment of Speech, Language and Hearing Sciences, University of Texas Austin, Austin, TX.
Sladjana LukicSchool of Communication Science and Disorders, Florida State University, Tallahassee, FL.
Maxime MontembeaultDepartment of Psychiatry, McGill University, Montreal, Quebec, Canada.
Kyan YounesDepartment of Neurology, Stanford University, CA.
Zachary MillerMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Adolfo M GarcíaCognitive Neuroscience Center, Universidad de San Andrés Buenos Aires, Argentina, Buenos Aires, Argentina.ORCID 0000-0002-6936-0114
Maria Luisa MandelliMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Virginia E SturmMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Bruce L MillerMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.
Maria Luisa Gorno-TempiniMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA.

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
Progressive Aphasia Cognition Anatomy and ProgressionR01NS050915 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI · 2004 to 2026
$11.0M
Emotion network dysfunction and decline in early frontotemporal dementiaR01AG052496 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Virginia Emily Sturm · 2017 to 2026
$6.9M
Connectomic imaging in familial and sporadic frontotemporal degenerationU01AG052943 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GORNO TEMPINI, MARIA LUISA, GROSSMAN, MURRAY · 2016 to 2019
$5.9M
Word fluency task performance as a marker of Alzheimer’s disease in Tagalog/English bilingual speakerR01AG080396 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jessica Anne Deleon · 2023 to 2026
$3.3M
Training program in the neurology of language and neurodegenerative aphasiasK24DC015544 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORNO TEMPINI, MARIA LUISA · 2016 to 2025
$1.9M
Preclinical markers of Alzheimer's disease using psycholinguistic semantic measuresR00AG066934 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONK, JET M.J. · 2022 to 2024
$1.2M
Primary Progressive Aphasia: Beyond the Clinical VariantsK23DC018021 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DELEON, JESSICA ANNE · 2020 to 2024
$995k
Neuroimaging and genetics of the glymphatic system in Alzheimer's diseaseK23AG090733 · NIA · STANFORD UNIVERSITY · PI Kyan Younes · 2025 to 2026
$332k
NIA NIH HHS K23 AG090733NIA NIH HHS P01 AG019724NIA NIH HHS P50 AG023501NIA NIH HHS R00 AG066934NIA NIH HHS R01 AG052496NIA NIH HHS R01 AG080396NIA NIH HHS U01 AG052943NIDCD NIH HHS K23 DC018021NIDCD NIH HHS K24 DC015544NINDS NIH HHS R01 NS050915
6 · The paper itself

Abstract

Background and Objectives: Within frontotemporal dementia (FTD), the behavioral variant (bvFTD) characterized by frontal atrophy, and semantic behavioral variant (sbvFTD) characterized by right anterior temporal lobe (rATL) atrophy, present diagnostic challenges due to overlapping symptoms and neuroanatomy. Accurate differentiation is crucial for clinical trial inclusion targeting TDP-43 proteinopathies. This study investigated whether automated speech analysis can distinguish between FTD-related rATL and frontal atrophy, potentially offering a non-invasive diagnostic tool. Methods: In a cross-sectional design, we included 40 participants with FTD-related predominant frontal atrophy (n=16) or predominant rATL atrophy (n=24) and 22 healthy controls from the UCSF Memory and Aging Center. Using stepwise logistic regression and receiver operating characteristic (ROC) curve analysis, we analyzed 16 linguistic and acoustic features that were extracted automatically from audio-recorded picture description tasks. Neuroimaging data were analyzed using voxel-based morphometry to examine brain-behavior relationships of regional atrophy with the features selected in the regression models. Results: Logistic regression identified three features (content units, lexical frequency, familiarity) differentiating the overall FTD group from controls (AUC=.973), adjusted for age. Within the FTD group, five features (adpositions/total words ratio, arousal, syllable pause duration, restarts, words containing 'thing') differentiated frontal from rATL atrophy (AUC=.943). Neuroimaging analyses showed that semantic features (lexical frequency, content units, 'thing' words) were linked to bilateral inferior temporal lobe structures, speech and lexical features (syllable pause duration, adpositions/total words ratio) to bilateral inferior frontal gyri, and socio-emotional features (arousal) to areas known to mediate social cognition including the right insula and bilateral anterior temporal structures. As a composite score, this set of five features was uniquely associated with rATL atrophy. Discussion: Automated speech analysis effectively distinguished the overall FTD group from controls and differentiated between frontal and rATL atrophy. The neuroimaging findings for individual features highlight the neural basis of language impairments in these FTD variants, and when considered together, underscore the importance of utilizing features' combined power to identify impaired language patterns. Automated speech analysis could enhance early diagnosis and monitoring of FTD, offering a scalable, non-invasive alternative to traditional methods, particularly in resource-limited settings. Further research should aim to integrate automated speech analysis into multi-modal diagnostic frameworks.

Identifiers

PMID39252889
PMCPMC11383468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.